NUVL as of Oct 31 · 20:19 ET
NUVLNasdaqPharmaceutical Preparations

Nuvalent, Inc. · Brief

Next report

4 days

Nov 5 · before openest.Q3 FY26

Expected move

No implied move.

Implied vs realized

8 reportsHistory
1 of 7≥ implied
avg implied
±7.5%
avg realized
±3.9%
Aug 8 '24—▲+4.15%—
Nov 12 '24±4.4%▼−3.60%×0.82
Feb 27 '25±7.6%▼−2.76%×0.36
May 8 '25±7.6%▲+7.31%×0.97
Aug 7 '25±6.4%▼−6.56%×1.03
Q3 FY25±13.6%▼−4.66%×0.34
Q1 FY26±8.0%▼−0.57%×0.07
May 7 '26±5.1%▼−1.78%×0.35
quarterimplied−15%0+15%realized×
May '26±5.1%▼−1.78%×0.35
Q1 FY26±8.0%▼−0.57%×0.07
Q3 FY25±13.6%▼−4.66%×0.34
Aug '25±6.4%▼−6.56%×1.03
May '25±7.6%▲+7.31%×0.97
Feb '25±7.6%▼−2.76%×0.36
2 older reports
Nov '24±4.4%▼−3.60%×0.82
Aug '24—▲+4.15%—
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 5 report · est.

Bull2 of 3

289managers reporting a position in the latest quarterly filings13F · Jun 30 '26
2 of 18largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

Bear1

25managers holding four fifths of reported value13F · Jun 30 '26
AI captions · Oct 7 '26once per report · top 2 per case

Linked exposure

NUVL report session

No linked exposure.

Latest changes

30 daysAll changes

No changes.

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.